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Paulson, Daryl S., M.S., 1977 Microbiology
Some ancifungal activities of guinea pig peritoneal exudate cells against 
Sporothrix schenckii. (46 pp.)
Director; John J. Taylor
Six guinea pig models were treated with schenckii conidia in various 
combinations to ascertain the effects of peritoneal exudate cells (PECs) 
on these conidia, to find whether or not those PEC effects were fungicidal 
or fungistatic to _S. schenckii conidia, and to determine the effects 
hydrocortisone acetate compromise had upon PEC activity. Phagocytic res­
ponses were measured using these 6 animal models which included animals 
immunized with viable conidia, animals immunized with non-viable conidia, 
untreated controls, animals compromised with cortisone but not immunized, 
animals both compromised and immunized with viable conidia and finally 
animals both compromised and immunized with non-viable conidia. Statisti­
cal analyses were used to compare the groups. It appears that animals 
immunized with viable conidia are more efficient in clearing these fungi 
via phagocytosis, that phagocytic rate and fungicidal properties are posi­
tively correlated, and that cortisone compromise, achieved through repeated 
cortisone injections into these animals, reduces both phagocytic ability 
and fungicidal properties to PECs.
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CHAPTER I 
INTRODUCTION
A. BASIC REVIEW MATERIAL 
Host/Parasite Relationship
For man and other animals, parasitic microbial Infection Is the 
Invasion of the host’s tissue by a multiplying microorganism which 
consumes the host’s nutrients, placing a strain on the host’s homeostatic 
ability. However, through the course of evolution, several effective 
and efficient antimicrobial defense systems have evolved: the Immune
system and the reticuloendothelial system which are Interfunctional.
Immune Sys t em
The immune system(47) composed of primary and secondary lymphoid 
tissue (spleen, thymus, lymph nodes, bone marrow, lymphocytes and Peyer’s 
patches) can be further divided into two cell type systems: the humoral
and the cellular Immune systems. The humoral system refers to those 
lymphoid cells whose primary function is to produce antibodies (glyco­
proteins) capable of binding non-covalently through electrostatic forces, 
van der Walls force, hydrogen bonding of hydrophobic/hydrophilic Inter­
actions with specific complementary antigens. These humoral cells (B cells) 
are bone marrow derived and are the precursor cells of Immunoglobulin 
secreting cells or plasma cells. The cellular lymphoid system consists of 
thymus derived lymphoid cells (T cells), which do not differentiate Into 
immunoglobulin secreting cells, but Instead produce lymphokines such as 
macrophage activation factors, macrophage inhibition factors, lympho- 
cytotoxlns. Interferon, activation factors for eliciting the humoral 
Immune response and chemotactic factors. They are responsible for hetero-
- 1-
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genous tissue graft rejection, they have the ability to directly lyse 
and destroy foreign cells Including certain tumors, and they are Involved 
In delayed hypersensitivity reactions.
Reticuloendothelial System
The reticuloendothelial system(5,44) Is composed of a network of highly 
phagocytic reticular cells lining organ tissues such as the spleen, the 
thymus, the liver (Kupffer’s cells) and the vascular endothelium of the 
tunica interna. In addition to these sessile cells, motile phagocytic 
cells occur In the peripheral pools as neutrophils, basophils, eosinophils, 
and monocytes. The macrophage, the end cell of the monocyte line and the 
phagocyte found In various tissue, Is free to wander by ameboid movement 
through tissue. It is especially concentrated within the loose connective 
tissue, but Is not restricted to that tissue. Specialized macrophages are 
found In the alveoli of the lungs (alveolar macrophages) and In the 
peritoneal cavity as peritoneal macrophages.
Peritoneal Exudate Cells
The cells of special Interest In this thesis are the peritoneal exu­
date cells (PEC) which Include PMNs, monocyte/macrophages, and lymphocytes 
but particularly the macrophage since It Is the most abundant cell normally 
found In the extravascular area of the peritoneal cavity.
Macrophage: The macrophage, derived from the circulating white blood
cell, the monocyte. Is a long lived and a very effective phagocytic cell 
In mammals(13,39,42). Electron microscopy has revealed that a unit mem­
brane exists In the macrophage which has many protuberances (microvilli) 
and Invaginations. The cytoplasm contains smooth and rough endoplasmic 
reticulum. IVo types of vacuoles have been shown to exist: a smaller
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pinocytic vesicle and a larger phagocytic vacuole. The macrophage ingests 
particles smaller than 0 .1pm by pinocytosis and engulfs particles of 
larger size through phagocytosis. It has a plasma membrane which is capable 
of recongnizing two of four subclasses of the human gamma immunoglobulin 
class, IgG^ and IgGg which differ only in their physicochemical composition 
in the constant globulin region(4). It can also recognize the complement 
fraction C3b. The macrophage has been shown to be capable of both non- 
immunologically and immunologically controlled phagocytesis/pinocytosis.
The macrophage has also been shown to attach to the Fc portion of 
the gamma immunoglobulin, which has previously been bound to an antigen. 
During phagocytosis, a particle is bound to the macrophage’s membranee 
receptors and surrounded by the cell membrane. The particle is then 
internalized into a phagosome and finally digested after the phagosome 
containing the particle and a lysosome have been fused(45).
Metabolism of the macrophage is dependent upon the activation state 
of the cell. An unactivated macrophage obtains energy primarily through 
anaerobic glycolysis but the activated macrophage has a significant increase 
in the hexose monophosphate shunt- A macrophage may become activated by 
exposure to lymphokines produced by sensitized T cells or by direct antigen 
contact. An activated macrophage is larger than the unactivated form, an 
activated macrophage adheres to glass more readily than an unactivated 
macrophage, and an activated macrophage is more phagocytic than an unact­
ivated type especially in phagocytosing complement-coated C3b, or IgG^ and 
IgGj coated particles. An activated macrophage also exhibits a greater 
chemotactic ability than the non-activated type.
Mechanisms of intracellular killing are not as well known in macrophages
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as in neutrophilic degradation involving myeloperoxidase» an acid pH, a 
halogen, and hydrogen peroxide. However, lysozyme and hydrogen peroxide 
are known to be of importance in the killing and degradationability by 
the macrophage.
The killing effect of the macrophage is related to the engulfed 
particle's chemical structure and to the activation of the macrophage.
The activated macrophage is especially efficacious in phagocytosing intra­
cellular organisms.
Neutrophil; The neutrophil, a phagocytic leukocyte(8 ), is also 
important as a PEC. The neutrophil, a polymorphonuclear leukocyte, 
accounts for about 60% of the total number of white blood cells contained 
in the peripheral blood pool, and is of secondary importance to the macro­
phage in this thesis only because it is not the major phagocytic cell 
line found in the peritoneal cavity. The neutrophil is a key cell in the 
phagocytic defense system because of its phagocytic effectiveness and 
efficiency and its quick response to microbial pathogens.
The neutrophil is 10-2Qium in diameter and is distinguished by its 
3-to-5 lobed nucleus held together by the nuclear envelope. Its average 
life span is 4 to 5 days and therefore, it is a short-lived cell. The 
neutrophil is extremely motile via ameboid movement and may become 
.chemotactic in the presence of certain attracting microbial products, 
tissue proteases, and C3b and C4b complement components. Opsonized micro­
bial organisms are more readily phagocytosed than non-opsonized ones and 
neutrophils having surface Fc receptors which recognize opsonins are very 
effective in phagocytosing opsonized microbial organisms in one of three 
ways(5,12): (1) by a specific IgG antibody/antigen complex; (2) by a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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specific IgG antibody/complement complex; or (3) by a non-specific compiiement 
fraction activated by a bacterial or fungal polysaccharide which forms iaii 
microbe/complement complex evoking phagocytosis. >ln
Phagocytosis of microbial organisms Is also educed by three additional 
factors: (1 ) by the proximity of an antigen and a neutrophil relative tmC
each other since the more packed together they are, the greater the pha*d 
gocytlc activity Independent of chemotactic or opsonizing factors; (2)>r t 
through natural antibodies other than IgG molecules synthesized for spœn?- 
Iflc antigens ; and (3) through leukoklnln, a type of IgG complex which Ic 
can coat the neutrophil’s surface stimulating neutrophilic phagocytoslsicu 
Ostensibly, the biological activity of leukoklnln Is dependent upon a Iv'j 
single peptide chain (Thr-Lys-Pro-Arg) named Tuftsin since It was dlsco%sr- 
ed at Tufts University(25).
The energy requisite for the neutrophil’s killing mechanism Is proch,' 
vlded by the glycolytic pathway. This pathway Is significant because 
neutrophilic phagocytosis often occurs In hypoxic surroundings such as n o 
abscessed lesions.
Once a microbe and a neutrophil have made contact, pseudopodia rop 
from the neutrophil extend and fuse on the far side of the microbe, encs&T- 
Ing It within a phagosome. The phagosome containing the microbe moves a p 
toward the cell’s center where It fuses with lysosomes (at a low pH)■coiâi 
talnlng myeloperoxidase, hydrogen peroxide, and a halide. Once fusion gif' 
these constituents has been completed, the microbe Is killed and degradiqd!. 
This Is an especially effective mechanism In phagocytic removal of e , 
Intercellular pathogens.
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B. SPECIFIC REVIEW MATERIAL 
Three Host/Parasite Models
Bacterial Model: The polymorphonuclear leukocyte is usually the first
cell to provide defense against pathogenic bacteria(4). Upon entry into 
a host, specific bacterial end products are chemotactic for neutrophils. 
Once a neutrophil has come in contact with a bacterial cell, the bacterium 
is phagocytosed. The phagocytic efficiency is enhanced if the bacterial 
cell has been previously opsonized, for example, by IgG antibody.
If the bacterial pathogen is a long-lived and/or an intracellular 
organism, the activated macrophage is more effective in its removal than 
the neutrophil. Mackaness(34) studied extensively the macrophage's role 
in intracullular bacterial infection. He introduced, intravenously, a 
sub-lethal dose of virulent Listeria monocytogenes into a mouse model 
and ascertained that it was initially removed by neutrophils and sessile 
cells of the reticuloendothelial system. However, monocytogenes was 
found to continue multiplying in these cells for 3 to 4 days after being 
phagocytosed. But after the 4th day, the bacterial population dropped 
off rapidly until monocytogenes was eliminated from the infected mice. 
The mice proved to be highly resistant to a rechallenge of these bacteria 
and suffered no pathological effects with a rechallenge of up to a LD^q 
dose of monocytogenes.
The reason for the high level of resistance was that the bacterial 
antigens stimulated the cellular immune system, elicited by the T lympho­
cytes, between the 1st and 2nd days of the challenge. The sensitized T 
cells released lymphokines such as macrophage activation factors and 
macrophage inhibition factors into the area where the T lymphocytes and 
bacterial cells interacted. The lymphokines activated the macrophages
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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and they readily phagocytosed the bacteria. Resistance to monocytogenes 
was long-lived in these mice due to the T memory cells which were capable 
of reactivating the macrophages upon a rechallenge and subsequent recogni­
tion of monocytogenes.
A different bacterial model, Mycobacterium tuberculosis, a long-lived, 
acid fast bacterium and the causative agent of tuberculosis, has provided 
similar results. With low level doses of M. tuberculosis in healthy, well 
nourished mammals, the disease is usually averted through neutrophilic 
phagocytosis. However, when M. tuberculosis is not completely destroyed 
by neutrophils, the activated macrophages become a preeminent factor in 
the phagocytosis of these bacteria.
In 1965, Lurie and Dannenburg(32), using inbred rabbits as hosts, 
studied macronhage/M. tuberculosis interaction. They concluded that resis­
tance or susceptibility to tuberculosis in the rabbits was dependent on 
the macrophage’s phagocytosing ability. In addition, when they injected 
cortisone into these rabbits, they found that the cortisone (which they 
thought prevented the fusion of the macrophage’s phagosome and lysosome 
bodies) severely reduced the macrophage’s ability to eliminate ^  tuberculosis, 
However, Hart and Armstrong(18) reported in 1974 that tuberculosis survived 
degradation in their study, even after being phagocytosed and both the 
phagosomal and lysosomal bodies had in fact fused.
Moreover, it had previously been shown in several studies that the 
cellular immune system accounted for a major portion of the phagocytic 
elimination of M. tuberculosis. For example, in 1960, Hsu and Kapral(25) 
compared guinea pig immune peritoneal macrophages with non-immune periton­
eal macrophages. They concluded that the immune and therefore activated 
macrophages were more effective in phagocytosing tuberculosis than 
non-immune macrophages
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Youmans and Youmans in 1969(48) reported that M. tuberculosis was 
not only eliminated faster by immunized (activated) macrophages than by 
non-activated macrophages, but the activated macrophages, immunized 
specifically for ̂  tuberculosis were as expeditious in removing non­
related organisms such as Lj_ monocytogenes as those macrophages sensitized 
with monocytogenes.
In a bacterial model using Salmonella typhimurium, a gram negative 
bacterium the causative agent of salmonella gastroenteritis, several 
studies (3,35) concluded that macrophages activated by T lymphocytes were 
more efficient in killing S. typhimurium than non-activated macrophages.
Also, it was reported that humoral components (B cells) were not a sign­
ificant factor in the activation of the macrophages against _S_j_ typhimurium.
Viral Model; Since viral infections are intracellular, macrophages 
may have an antiviral function in this type of infection (2,37). T 
lymphocytes, upon recognition of viral antigen, release lymphokines which 
in turn activate macrophages. These activated macrophages then pinocytose 
the free virus particles. It has been demonstrated in vitro that activated 
macrophages do restrict intracellular replication of some viruses through 
phagocytoses. It has also been shown that activated macrophages protect 
new born mice from herpesvirus infection(19). There is evidence that 
macrophage-produced interferon offers resistance to general viral infections; 
however, no conclusive evidence has been shown to date.
Fungal Model: Studies pertaining to subcutaneous and systemic fungal
infections in mammalian hosts have been neglected, for the most part, rela­
tive to the extensive and intensive studies conducted upon bacterial and 
viral models. One reason for this is the low invasiveness many fungi have 
upon healthy and well nourished mammals. However, with the advent of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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broad-spectrum antibiotics, synthetic anti-inflammatory drugs such as the 
corticosteroids, and present oncological treatment methods (eg. chemo­
therapy), the occurrence of fungal diseases such as candidiasis, mucoirmy- 
cosis, cryptococcosis, and aspergillosis has been increasing significantly 
(29.45).
Natural resistance appears to be a major factor in protecting the 
host against pathogenic subcutaneous and systemic fungal infections. 
Neutrophils rapidly provide initial protection against these organisms 
until the macrophages become activated. Once activated, macrophages can 
be effective antifungal agents especially in, for example, fungal infect­
ions like Cryptococcus neoformans.
Early attempts(28) in 1925 by Shapiro and Neal and Hoff in 1942, and 
Macus and Rambo(36) in 1955 failed to find an immunization treatment for 
or an immune mechanism to explain cryptococcosis relative to the humoral 
immune system.
Gadebush(14) in 1958, provided an interpretation of natural immunity 
against Cj_ neoformans in rabbits which was accepted as valid. He intro­
duced C. neoformans into rabbits through aerosols. Once C. neoformans 
was situated in the alveolar septa and the alveoli of the lungs, the 
majority was removed within 24 hours by neutrophils. However, the fungi 
that were not phagocytosed by neutrophils proliferated freely. The phago­
cytic obligation soon shifted to the monocyte. It is thought that during 
this shift the fungi spread into areas outside the pulmonary tract(15). 
After several days, the monocytes which initially confronted C_̂  neoformans 
matured into macrophages. They and other macrophages were activated by 
delayed hypersensitivity reactions as both an effect of the cellular 
immune response and through previous contact with the fungi as monocytes.
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-10-
i.e., direct contact activation. The existing C. neoformans were then 
swiftly phagocytosed and destroyed. Complete recovery from this infection 
was common if the infective neoformans dose was not so massive as to 
overwhelm the host*s system.
Abrahams (1) in 1966 demonstrated that natural resistance to crypto­
coccosis in mice was dependent on the cellular immune system and not the 
humoral system directly. However, it was demonstrated that opsonization 
of these fungi by IgG greatly enhanced phagocytosis. Abraham’s findings 
were supported by Goren(17) in 1967.
Rabbit Macrophage; In previous study in our laboratory(11) it was 
found that alveolar macrophages may be activated by either viable or non- 
viable schenckii conidia regardless of the route of administration.
It was discovered that fungicidal activity was 2-to-3 fold greater in 
those macrophages which had been recovered from animals sensitized by 
aerosols than from those sensitized by intramuscular, intravenous, or 
intraperitoneal injections of equivalent numbers of conidia.
S. schenckii Neutrophil Model: In 1973, Howard(23), using guinea
pig neutrophil cell cultures, demonstrated that neutrophils were highly 
effective in killing extracellular Histoplasma capsulatum fungi cells. 
Other studies (24) have also <^hown that neutrophils are highly effective 
against certain extracellular fungi, such as Candida albicans, krusei, 
parapsilosis, stellatordia, pseudotropicalis. Saccharomyces cerevisiate, 
Geotrichium canidium, Aspergillus niger, fumigatus, and neoformans.
Macrophage Model: Howard(20), in 1959 maintained normal (noniramune)
mouse peritoneal exudate macrophage cultures inoculated with yeast phase
H. capsulatum. He found that as few as 30 fungus cells per macrophage 
overwhelmed the macrophages.
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In 1965, Howard(21) expanded his previous studies dealing with 
nonimmune mouse macrophages to other models. He used five different 
isolates of capsulatum; he used both guinea pig and mouse normal 
macrophages, and he used guinea pig and mouse macrophages in the pre­
sence of specific hyperimmune serum and macrophage cells from specific­
ally immunized guinea pigs and mice. He concluded that the generation 
time of H^ capsulatum in mammalian macrophages was very constant, that 
the rate of growth for the five 11^ capsulatum isolates was very similar 
in macrophage cells; that the generation time of fungus within guinea 
pig macrophages was nearly the same as in mouse macrophages, and that 
the exposure of yeast phase H^ capsulatum to antibody and complement 
did not affect intracellular fungal proliferation in the macrophages.
He reported no significant difference in fungus proliferation within 
macrophage cells from immunized compared with those from nonimmunized 
guinea pigs and mice.
In 1973 Howard(22) used freshly harvested macrophages from immunized 
mice instead of those grown on tissue cultures. He found that H. capsulatum 
was inhibited by these immune activated macrophage cells but was not killed.
In 1976 Howard and Otto(24) reported that the effectiveness of inhibit­
ion of _Ĥ  capsulatum was a product of the cellular immune system and not 
the humoral system.
Kashkin et al.(27) in 1976, using the pathogenic fungi Coccidioides 
immitis, the causative agent of the pulmonary infection coccidioidomycosis, 
reported a similar finding that fungicidal and fungistatic responses are 
dependent upon the cellular immune system which activated the peritoneal 
macrophages. This is important to this author's research in that the 
fungicidal and fungistatic effects of the cellular immune system against
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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S. schenckii shall be studied.
Statement of Purpose
This author proposes a slightly different approach In continuing 
pathogenic fungal .research. The previously cited fungal models used 
fungi that are not normally encountered by peritoneal exudate cells, 
particularly peritoneal macrophages. capsulatum. C. neoformans. and
G. Immltls are basically pathogenic to the pulmonary system. To date 
no study concerning a subcutaneous fungus/PEC model has been reported. 
Hence, It Is felt that a guinea pig model using schenckii would be 
of significance since peritoneal exudate cells do normally encounter 
subcutaneous pathogenic fungi.
Therefore, the purpose of this thesis Is to determine some anti­
fungal properties of guinea pig peritoneal exudate cells when chal­
lenged by the pathogenic fungus, S_̂ schenckii. the causative agent of 
sporotrichosis, a lymphocutaneous Infection.
The first question to be evaluated Is: what phagocytic effects. If 
any, do guinea pig peritoneal exudate cells have upon ̂  schenckii?
The second question to be evaluated Is: given phagocytosis does
occur. Is It fungistatic or is It fungicidal?
The thlru questions to be evaluated Is: what are the effects of
cortisone compromise on PEC activity?
Plan of Development
In this study, ^  schenckii conidia will challenge thloglycolate- 
Induced guinea pig peritoneal exudate cells In three specific modes: 
normal. Immune, and Immune suppressed.
1. Normal condition: Defined as a guinea pig having had no previous
exposure to S. schenckii. This is also the control condition.
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2. Immunized condition: Defined as a guinea pig having been immu-
nized for both a primary and a secondary response against S. schenckii 
antigens and therefore presumably capable of antigenic memory and macro­
phage activation.
3. Immune suppressed condition: Defined as the state in which the 
capacity to elicit the immune response has been greatly reduced by the 
use of corticosteroids.
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CHAPTER II 
MATERIALS AND METHODS
Animal Models
Guinea pigs, the animals models used in this research, were obtained 
from Rocky Mountain Laboratories, Hamilton, Montana, were housed in the 
animal room at the Department of Microbiology, were approximately the 
same age, were immune competent, and were fed a nutritionally complete 
commercial guinea pig ration.
Fungal Cultures
Cultures of ^  schenckii, strain 425, were obtained from stock cultures 
stored at the Department of Microbiology, University of Montana. Subcul­
tures of schenckii were inoculated onto Mycosel agar (Baltimore Biolo­
gical Laboratory) slants; were incubated in screw cap tubes at 25°C, and 
stored at minus 20°C. Before any S_̂  schenckii culture was employed, the 
culture was examined for contamination through microscopy and gross 
observation. Broth cultures used for harvesting condia contained 150 ml 
Sabouraud dextrose broth (Difco Laboratories) combined with 0.1% yeast 
extract (Difco Laboratories). For conidia harvesting, a subculture of S. 
schenckii was streaked on a Mycosel agar plate, which was incubated at 25°C 
for 96 hours. After incubation, a 0.5 X 0.5 mm section of agar containing
S. schenckii was removed and inoculated into a 500 ml Erlenmeyer flask con­
taining 150 ml of the conidia broth described above. Each inoculated flask 
was then incubated at room temperature on a horizontal shaker for 10 to 
12 days. At this time, the conidia were harvested by transferring about 
75 ml of each broth culture into a 250 ml sterile plastic centrifuge bottle. 
The bottles were centrifuged at 75 x G, at 4°C, for 10 minutes and the
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supernatant was discarded, leaving In each centrifuge bottle a pellet mass 
of conidia. To each of the plastic centrifuge bottles, 100 ml of sterile 
physiological saline (0.85%) were added. The bottles were hand agitated 
25 times to Insure an adequate washing of the conidia. The conidia were 
then recentrifuged as previously described and after centrifugation, a 
second conidia washing was performed. These washed conidia were stored 
In the plastic centrifuge bottles at minus 20°C for future use as either 
cellular antigens or for use In establishing the effectiveness of PEC 
phagocytosis In vitro.
Tissue Culturing Media
Eagles Minimum Essential Media (MEM) with Earles' balanced salt 
solution (Microbiological Associates) was the tissue culture medium 
employed. Two grams crystalline MEM were reconstituted In 1,000 ml triple 
distilled water, buffered with 2.2 grams NaHCO^, and the hydrogen Ion 
content was adjusted to pH 7.2 using 1 N NaOH or 1 N HCl depending upon 
the acid or base concentration. This completed medium was filter steri­
lized using a Seitz filter, pore size 0.22fim and stored at 4°C.
For the tissue culturing process, 100 ml MEM was enriched with 2% 
heat Inactivated fetal calf serum (Microbiological Associates), 1 ml 
trlclne (Sigma Chemical Co.) as a buffering agent, 10,000 units penicillin 
G (Sigma Chemical Co.) and 10,000 pg streptomycin sulfate (Sigma Chemical 
Co.) each to Inhibit gram positive and gram negative bacterial growth 
respectively, 1 ml heparin (Sigma Chemical Co.) to prevent clumping of 
red blood cells and 1 ml L-glutamlne (Sigma Chemical Co.) to ensure ade­
quate levels of this amino acid. In this thesis, this solution shall be 
known as complete MEM.
Phosphate Buffered Saline (PBS) was utilized as a physiological buffer-
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ing agent and in the tissue culture washing process to be described later. 
Stock solutions of PBS were prepared as described by Dulbecco and Vozt(9). 
Glassware
All glass items utilized in this work were first rinsed in cool water 
to avoid protein coagulation, then washed in warm soapy water, rinsed 5 
times in distilled water, and finally acid rinsed for a minimum of 4 hours 
in a 0.1 N HCl immersion bath. In cases where direct contact between PECs 
and glassware occurred, those glasswares were siliconized with Silaclad 
(Biological Associates) with the exception of the 15 mm-diameter cover 
slips positioned in the bottom of each culture well in order to augment 
PEC adherence.
Antigen Preparations
Two types of cellular antigens were used in this work; viable and 
non-viable S. schenckii. (1) Viable S. schenckii; As required, samples 
of schenckii conidia were transferred from the 250-ml plastic centri­
fuge bottles, plated on Mycosel agar, incubated at 25°C, and inspected 
for growth on the 5th day of incubation in order to ensure viability. 
Preparations of viable conidia were produced by adding conidia to sterile 
physiological saline until a concentration of 1 0  ̂conidia per ml saline 
was achieved. These viable conidia preparations were stored at 4°C in 
screw cap bottles. (2) Non-viable S. schenckii: S. schenckii viable
conidia were added to a 1 :1 0 , 0 0 0 concentration of merthiolate, incubated 
at 35°C for 24 hours and washed in PBS to remove the merthiolate. This was 
accomplished by centrifuging the merthiolate aliquot for 15 minutes at 4®C, 
at 75 X G. Once completed, the merthiolate supernatant was decanted 
followed by the addition of 50 ml PBS. This mixture was hand agitated 25 
times to ensure adequate washing, followed by recentrifugation as previously
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described. At this time, a sample of the conidia from this washed 
aliquot was plated on Mycosel agar, incubated at 25°C, and inspected 
for growth after 72 hours. Non-viability was validated by the absence 
of any conidia growth when plated on Mycosel agar. Non-viable conidia 
were also stored at a 1 0  ̂conidia per ml physiological saline concen­
tration at 4°C in screw cap bottles.
Experimental Models
Group I: This, the control group, received neither an immunization
of fungal conidial antigen or cortisone.
Group II; This group was immunized with merthiolate-treated, non- 
viable S_̂  schenckiL conidia. The guinea pigs in this group were initially 
immunized intraperitoneally at day 1 with a 1 0  ̂ conidia dose followed by 
a second 10^ conidia dose at day 11, and the PECs were extraced at day 22.
Group III: The animals in this group were immunized with schenckii
viable conidia. Each animal received two 10^ doses of viable conidia, the 
first at day 1 and the second at day 1 1 , administered intraperitoneally. 
PECs were collected at day 22.
Group IV: The guinea pigs in this group were administered hydro­
cortisone acetate (Sigma Chemical Co.) but no fungal antigen. Each animal 
received 0.05 mg hydio-cortisone acetate (cortisone) per gram body weight 
intraperitoneally at 5-day intervals until day 22. At this time the PECs 
were removed.
Group V: This group was treated with cortisone and immunized with
non-viable _Ŝ  schenckii conidia. Two days prior to the first 10^ non- 
viable conidia immunization, 0.05 mg cortisone per gram body weight was 
injected intraperitoneally into each guinea pig; the injection was repeated 
at 5-day intervals until day 22. Non-viable conidia in a 10^ dose were
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injected into each animal at days 1 and 1 1 , followed at day 22 with the 
collection of PECs.
Group VI: This group was injected with cortisone and immunized with
viable ̂  Schenckii conidia. Guinea pigs received 0.05 mg dose of cortisone 
per gram body weight intraperitoneally 2 days prior to the first immunization 
of 10^ viable conidia. Cortisone was readministered at 5-day intervals 
thereafter until day 22. At days 1 and 11, non-viable conidia were 
injected into each guinea pig intraperitoneally and at day 22 the PECs were 
collected.
It should be mentioned that in each of these 6 models, 72 hours prior 
to removal of the PECs (or on day 19), each guinea pig was induced with an 
injection of 4 ml of thioglycolate fluid medium (Difco Laboratories) intra­
peritoneally.
In Vitro Methodology
In order to study the in vitro effects of PECs when exposed to S. 
schenckii conidia, PECs were introduced to viable conidia through a tissue 
culturing procedure.
Procedure
1. At day 22, 20 ml complete MEM was injected intraperitoneally via 
an 18 gauge needle into each guinea pig. This was followed by a gentle 
massage of the abdominal area for approximately 1 minute to increase the 
number of PECs collected. At this time the needle was removed from its 
syringe and replaced, bevel up, into the initial puncture wound at an acute 
angle of 20-40° from the plane of the guinea pig's abdomen until it was in 
the peritoneal cavity. A prechilled 40-ml sterile siliconized centrifuge 
tube was held under the needle's butt to collect the returning PEC suspension. 
To ensure the maximum recovery of the PEC suspension, a gentle downward 
abdomen milking was provided each animal.
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2. After the PEC/MEM aspirates were collected from each of the six 
guinea pig models, they were centrifuged 5 minutes, at 4°C, at 75 X G, 
in the 40-ml centrifuge tubes.
3. Once centrifugation was completed, the supernatant was aspirated, 
leaving a pellet of PECs at the bottom of each of the tubes. At this point 
1 ml 9.17 M Tris-(hydroxymethyl)-aminomethane (Sigma Chemical Co.) and 9 ml
0.83% NH^Cl were added to each centrifuge tube containing the PECs. This 
suspension was allowed to stand at room temperature for 15 minutes to en­
sure lysis of any red blood cells collected.
4. The cells were then re-centrifuged as in step 2 followed by aspi­
ration of the supernatant fluid. Once completed, 10 ml PBS were added to 
each centrifuge tube to wash the PECs, followed by centrifugation as in 
step 2 .
5. At this point, the supernatant was aspirated and the PECs were 
resuspended in 5 ml of complete MEM per each centrifuge tube. A small 
volume of PEC/MEM suspension from each tube was collected and placed on 
a hemocytometer. The PECs were then counted by standard methods(4) and 
these counts estimated the number of PECs per ml within the tubes.
Complete MEM was added to each of the 40-ml centrifuge tubes until a 10^
PEC count per ml was confirmed via counting.
6 . After a uniform cell count of 10^ cells per ml was achieved for 
each of the 6 models, 1 ml PEC aliquots were added to each of the 24, 1.7 
X 1.6 cm wells contained in each flat bottom tissue culture plate (Flow 
Laboratories). Each well in tissue culture plates contained a round 15 
mm flat non-siliconized glass cover slip for PEC adherence.
7. These tissue culture plates were incubated at 37°C in 0.4% CO^ 
for 45 minutes. At this time any non-adherent PECs within each culture
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well were removed by dispensing 5 ml PBS into each well simultaneously 
removing the PBS/MEM solution through a Pasteur pipette via negative 
pressure. To prevent the PECs from osmotic shock, approximately a 2 mm 
layer of PBS covering the adherent cells on the coverslips was not 
removed. Quickly, 1 ml of MEM was reintroduced into each of the tissue 
culture wells. Once completed, the PEC tissue culture plates were re­
incubated. Refeeding was performed every 4 hours in an identical manner 
until the PECs had been cultured for a total of 12 hours. It was found 
that 12 hours incubation was necessary for an even monolayer of PECs to 
form on each of the cover slips.
8 . At hour 12, each of the tissue culture wells was washed with 5 
ml PBC as stated in step 2, followed by the introduction of 10“̂ viable
S. schenckii conidia suspended in 1 ml of complete MEM.
9. At times 0, h, %, 1, 2, 4, 8 , and 12 hours, a cover slip con­
taining adherent PECs, representing each of the 6 models, was removed 
from the appropriate tissue culture well, washed in physiological (0.85%) 
saline, and stained with a 1 :1 0 , 0 0 0 dilution of acridine orange in a 
modified procedure described by Newcomer(40). Following the acridine 
orange staining method, conidia which are viable appear bright green while 
conidia which are non-viable appear orange or red when examined with fluo­
rescence microscopy.
10. Two methods of conidia counting were employed. In the first 
method, 20 PECs, selected at random, were observed microscopically. The 
number of conidia contained within each of these 20 phagocytes was tabu­
lated and averaged. The second counting method used the same data as the 
first except any of the PECs not actually demonstrating phagocytoses via 
the acridine staining method were dropped from the tally and an adjusted
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average number of conidia phagocytosed per PEC was calculated. This was 
performed in order to allow for the possibility that the PECs which did 
not demonstrate intracellular conidia may have been non-viable PECs 
instead of viable, non-phagocytosing PECs.
Quantitative Analysis
The Statistical Package for Social Science (SPSS) computer program 
format was employed on the University of Montana’s DEC-20 computer system 
when possible. When hypothesis testing was encountered, the 0.05 level 
of significance (95% confidence) for type I error was used. When appro­
priate, the descriptive level of significance or P value is given. This 
is defined as the probability of realizing an observed value or a more 
extreme value, given that the null hypothesis of equivalence amount models 
is true.
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CHAPTER III 
RESULTS
Plotted on figure 1 are the average numbers of phagocytosed conidia 
per PEC, for each of the 6 models based on microscopic observations of 
20 randomly selected PECs per model, plotted vs time in hours. Note that 
the time intervals from time zero, when viable conidia were first intro­
duced into each tissue culture plate wells, to the first observed cyto­
toxic effects of these PECs on the conidia are also provided. Table 1 
provides the mean data of these observations from which graph 1 was plotted.
Figure 2 provides the plot of the average number of phagocytosed 
conidia for each guinea pig model relative to time; however, this graph 
portrays only those PECs having actually demonstrated phagocytosis of 
conidia. Those PECs having not phagocytosed any conidia as demonstrated 
microscopically by means of the acridine staining procedure, were dropped 
from this statistical design. Table 2 provides the mean data from which 
Figure 2 was plotted.
A standard 1-factor, 2-way analysis of variance(46), Table 3, was 
computed using the mean data contained in Tables 1 and 2 and other 
required parameters, for example, che errors of the means, sums of squares,
F statistics and variances of these sample data necessary in this Anova 
design were computed from the raw experimental data. Computational analysis 
was performed through an ANOVA SPSS computer program(41), followed by both 
the computation of 4 multiple contrasts and hypotheses testing by this author, 
using a hand-held programmable HP-41C calculator. Since the same relative 
statistical results were achieved when using the data from either Table 1 
or 2 , (as confirmed through a non-pararoetric statistical process involving
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Variation Degrees Sum of
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Due time 7 296.3 42.33 5.21 1.57
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a modified Chi Square procedure(38) measuring a goodness of fit which 
provided a P value of 0.005, which is the probability of a significant 
difference between the average data contained in Tables 1 and 2, which 
is insignificant), only those data based solely on those PECs containing 
intracellular conidia (Table 2) will be used throughout the remainder of 
this work.
Based on the 2-factor 1-way ANOVA using the data on Figure 2, two 
separate groups of models could be isolated: the first group, the model
immunized with viable conidia; and the second group, which contained the 
other 5 models, which as a unit, were less efficient in antifungal 
properties. It can be seen that the PECs extracted from guinea pigs immu­
nized with viable conidia were the most effective of those models tested, 
in both their phagocytosing and their fungicidal activity against schen­
ckii. The probability of this group not being the most efficient and active 
phagocytic group studied is less than 0.001. This group phagocytosed an 
average of more than 20 conidia per PEC within the 8 hour time frame and 
that intracellular counting of PECs had to be terminated at hour 8 , 
because the numbers of intracellular conidia could no longer be accurately 
counted, since the PECs were literally "stuffed" with intracellular conidia. 
The phagocytic rate between hours 1 and 4 was about 7 conidia per hour, 
which was more than double the average rate of any of the other 5 groups. 
Intracellular conidia lost viability less than 2 hours after initial 
exposure to PECs in this group as demonstrated by the acridine orange 
staining procedure.
The non-cortisone compromised animals immunized with non-viable conidia 
and the control group were statistically comparable in both fungicidal effects 
and phagocytic effects, phagocytosing an average of 8 - 7 conidia per PEC 
respectively within 12 hours. The first fungicidal effects against the
conidia appeared about 4 hours after initial exposure to the PECs.
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Neither phagocytic nor fungicidal activity of PECs from any of the 
cortisone compromised animals sensitized with viable conidia differed 
significantly from the normal untreated, unsensitized animals. The phago­
cytic efficiency of PECs from the compromised animals challenged with 
non-viable conidia was minimal and did not differ significantly from the 
unchallenged animals. The first fungicidal effects against the conidia 
appeared 8 hours after initial exposure to the PECs for each of the 3 
compromised groups.
Using only one animal from each model for each experimental run 
attributed to large internal statistical variations, causing loss in 
quantitative precision via the 1-way, 2-factor ANOVA procedure. To 
achieve a greater degree of quantitative resolution through statistical 
analysis, a nested ANOVA design(lO) was programmed into the DEC-20 
computer system, using the SPSS format. Unlike the 1-way, 2-factor 
ANOVA design, which contrasted the variation of the 6 guinea pig models 
to each other based on time, the nested ANOVA design provided a 3-dimen­
sional test by comparing the variation among the 6 guinea pig models based 
on time with the additional subsample contrast, that of phagocytic varia­
tion among PECs, both within each of the 6 models (internal variation) 
and between each of the 6 guinea pig models. Since a statistical sampling 
procedure had been violated using the nested ANOVA design in that for each 
model, several guinea pigs within that model should have their extracted 
PECs pooled, but did not, the P value is significantly high (the probabi­
lity of this nested ANOVA design being untrue is P=0.30), which provided a 
higher probability of being incorrect than the 2 factor 1 way ANOVA of 
P 0.001 does.
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Via the nested design, 3 distinct animal groups, based on phagocytic 
efficiency, could be realized using multiple contrast analyses based on 
the data contained in the Nested ANOVA Summary table. Table 4. The most 
obvious difference between the 3 groups appeared in the animal model immu­
nized with viable conidia. Within the other 2 models, separated via the 
nested design, was the second most efficient phagocytic group consisting 
of 3 models: the normal animal model immunized with non-viable conidia,
the normal control model, and the cortisone compromised model immunized 
with viable conidia. These three models were statistically identical at 
the 95% confidence level based on their similar phagocytic efficiency.
The third group isolated and the least efficient of the 3 models included 
the two remaining cortisone compromised models, those animals immunized 
with non-viable conidia and the cortisone compromised control animals.
The probability of this third group being statistically identical to the 
second class in phagocytic efficiency is 0.30.
Of concern in this work was the possible bias effects that both 
differences in sex and age might have in this study. Prior to actually 
initiating any of the phagocytic and fungicidal assays as described in 
this thesis, a multiple/partial and a partial regression analysis were 
performed using the SPSS and BASIC programming formats. .Four experimental 
contrasts were devised using a 2 X 2 factorial format similar to those 
discussed by Cochran and Cox(6 ) so as to ensure that each animal model 
was both age and sex adjusted. That is, each model was randomly assigned 
1 of 4 variables: an older guinea pig, a younger guinea pig, a female guinea 
pig, and a male guinea pig. Each of these variables was then used one time 
within each model during the 4 experimental runs used in completing this 
study. Internal variation within each model was then measured and a
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Partial F Test ANOVA procedure(28) was employed (Table 5), measuring 
first the variation explained solely by phagocytic variation due the 6 
treatments which was high (F computed = 19.67). Next the variable, 
sex, was measured to find how much additional phagocytic variation 
could be explained through this influence. As can be seen on Table 5, 
the additional phagocytic variation explained by sex is negligible (F 
computed -> 0.08). Next the sex variable was removed and the guinea pig 
factor tested. The amount of phagocytic variation explained solely by 
age was also negligible (F computed = 0.03). Finally, both variables, 
age and sex, were simultaneously measured to find their joint contribut­
ion to explaining phagocytic variation. Again, the contribution in 
explaining additional phagocytic variation was negligible (F computed = 
0.11).
Hence, it can be concluded that sex and the age differences in this 
work did not bias the phagocytic results at a probability level of con­
fidence of 0.999.
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c ha pt e r IV 
DISCUSSION AND CONCLUSIONS
The immunological mechanisms of resistance to the pathogenic fungus 
S. schenckii are not fully understood. According to the literature, the 
PEC/fungus relationship is similar to the PEC/bacterium relationship, in 
that when conidia or bacteria are encountered in a wound such as a trau­
matic implantation within cutaneous tissues, neutrophils play a paramount 
antimicrobial role since they are physically present at the wound site 
from the onset of the inflammatory process. Since neutrophils require 
no activation to initiate efficient phagocytosis, this phagocytic res­
ponse occurs whether or not the animal has been previously immunized 
against that foreign body. In both human mycoses and bacterial infect­
ions, neutrophils soon become of lesser phagocytic importance against 
those organisms, relative to the activated macrophage, once T-cell secre­
tion of lymphokines such as MAP and MIF has occured mainly due to the 
lower numbers of neutrophils but higher number of activated macrophages 
found in cutaneous tissue. Also, the physically smaller neutrophil 
simply is not capable of phagocytosing the large number of microbial 
organisms that the macrophage can.
However, a significant post-phagocytic difference between the bac­
terial and fungal models may exist. Recall that once a bacterial or 
fungal cell comes in physical contact with a neutrophil, pseudopodia 
from this white blood cell extend and surround the organism, encasing it 
within a portion of inverted plasma membrane, the phagosome. Once the 
organism is encased in the phagosome, the entire body, assisted by micro­
tubules, moves toward lysosomes(25). Once the phagosome and lysosomes
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come in physical contact, they fuse, exposing the organism to an environ­
ment of low pH, myloperoxidase, hydrogen peroxide, lactoferrin, glyco- 
sidases, proteases, lipases, granular cationic proteins, and a halide, 
usually iodide. For the majority of bacteria, the fate is degradation 
but this may not be the case with fungi. Fungi have cell wall structures 
significantly different biochemically from either gram negative or posi­
tive bacteria. The fungal cell wall consists mainly of polysaccharide 
polymers of cellulose, of chitin, of beta-glucans, and of mannans, either 
in combination with each other or appearing as single repeating polymers. 
Mammalian PECs are known to lack enzymes capable of degrading these 
unique polysaccharide configurations, even after intracellular killing 
of these fungi has been demonstrated(7). Therefore, the retention of 
fungal bodies may persist intracellularly. This may play a significant 
role in human resistance to fungal infections since most of the non- 
degradable fungal cells are partially degraded by phagocytes. This 
partial degradation, however, is at best, slow, hence it may provide an 
immunological "boosting" effect by intensifying the immune response.
Some disagreement exists as to whether non-viable fungal antigens 
are as immunogenic to a mammalian host as viable fungal antigens. Howard 
(19) reported that immune peritoneal macrophages in both mice and guinea 
pigs were activated to a greater extent when immunized with viable H. 
capsulatum than with non-viable H. capsulaturn conidia. Others (13,14,47) 
have reported similar findings. However, using rabbit models, Ferguson 
(1 1) reported that activation of alveolar macrophages was relatively con­
stant regardless of whether viable or non-viable S_̂  schenckii were admini­
stered as antigens. Using bacterial models, Mackaness(34) reported that 
viable L. monocytogenes were more antigenic than non-viable L . monocytogenes.
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as did others(2>36,37) using various other bacterial models. It appears 
then that both viable fungi and viable bacteria are generally more 
antigenic than non-viable types. From the results of this present work, 
it has been demonstrated that viable conidia are more highly antigenic 
than non-viable S. schenckii conidia when administered into guinea pigs.
Both the phagocytic rate and the numbers of conidia phagocytosed by PECs of 
normal animals immunized with viable conidia were at least twice that of 
the PECs from animals immunized with non-viable conidia. Also, from these 
results, it can be seen that both those animals immunized with non-viable 
conidia as well as the non-immunized controls were equivalent in phagocy- 
totic ability, which probably means that immunization with non-viable 
conidia has no detectable effect on the immune system in terms of PEC 
activation. In the present study, the results obtained through the 2- 
factor, 1-way ANOVA statistic, indicate that these 6 guinea pig models 
could be separated into 2 groups based on their phagocytic effectiveness.
The most efficient animals in phagocytotic ability were those immunized 
with viable conidia. The other 5 models were statistically indistinguish­
able from each other. The conclusions reached using this statistical 
analysis are probably not complete in describing the phagocytic variation 
amoung the 5 models contained in group 2 , since it may corsist of 2 separate 
subclasses. With a more sensitive nested ANOVA design, it was determined 
that 3 separate classes may exist within the 6 models. The most effective 
phagocytic group consisted of those animals immunized with viable conidia.
The second most effective group consisted of 3 animal models: control
animals immunized with non-viable conidia; animals compromised with cortisone 
and immunized with viable conidia; and animals immunized with non-viable 
conidia. These models were equivalent in phagocytic efficiency. The third
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and least effective group isolated by this statistical process was 
composed of the two cortisone-compromised animal models, those immunized 
with non-viable conidia and the non-immunized controls.
Unfortunately this nested design is not above reproach as protrayed 
by the relatively low (0.70) probability of being the correct model of 
representation, because the requirement for pooling guinea pig PEC samples 
within each of the 6 models was not met: too large a number of guinea
pigs would be required for such a test. However, the 3 phagocytic group 
models appear logical and may be quite valid.
Note that the normal controls and the cortisone-compromised models, 
both those immunized with viable conidia and those non-immunized, are 
equivalent in phagocytotic efficiency. Cortisone is known to prevent the 
fusion of phagosomes and lysosomes(16) which leads to the inhibition of 
enzymatic degradation and alters the plasmalemma inhibiting phagocytosis. 
It is also known that cortisone is lymphotoxic and may lead to reduction 
in the number of T lymphocytes which are required in PEC activation, as 
well as to increased release of neutrophils from the bone marrow into 
peripheral blood pools.
It is possible that the cortisone-compromised anamals which were 
immunized with viable conidia demonstrated PEC activity equivalent to 
the non-immunized control group because immunization with highly antige­
nic viable conidia may have compensated for the immune-compromising 
effect of cortisone treatments.
Examining the last group, those models cortisone-compromised and 
immunized with non-viable conidia and the non-immunized cortisone- 
compromised group, it can be argued that there was a more dramatic 
repression of the immune response, because this group, based on the
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nested ANOVA design, was least efficient in phagocytosis than the other 
model groups.
Using lower levels of cortisone and/or different injection inter­
vals might have produced other results. For example, it was discovered 
that a dose of 0.005 mg cortisone per gram animal weight had little 
repressive response on the guinea pig immune system, nor did a 0.05 mg 
per gram body weight cortisone injection, administered in 3 divided 
doses at ten-day intervals. Conversely, it was found that a 0.05 mg 
cortisone per gram body weight injection administered in 7 divided doses 
at 2-day intervals killed all guines pigs receiving that treatment, per­
haps because the animals lost all immunological resistance or suffered 
toxic effects of the drug. Hence the 0.05 mg cortisone per gram body 
weight administered in 5 divided doses was found most suitable for this 
work.
A significant point in this research was the association between 
PEG activation states and cytotoxic activity. One can see (Fig. 1) that 
fungicidal effects occurred with those conidia phagocytosed by the non­
cortisone compromised animals and immunized with viable conidia within 
half the time required for fungicidal effects to be first noticed in the 
non-cortisone compromised animals immunized with non-viable conidia and 
the normal controls. This observation has not previously been reported. 
One would, of course, expect the fungicidal effects of the cortisone- 
treated animals to be reduced for reasons stated above.
Controversy exists as to the role of the humoral immune system in 
relationship to mycotic disease. Recall that antibodies are produced 
in most mycotic infections. Their production of course depends in part 
on actual physical contact between fungi and/or fungal metabolites and/ 
or B lymphocyte recognition of those antigens.
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In the case of acute respiratory infection as in histoplasmosis,
(caused by capsulatum) detectable IgG, IgM, and IgA immunoglobulins 
corresponding to capsulatum protein and polysaccharide antigens can 
be demonstrated from 10-14 days after the initial exposure to the fungus. 
Medically, to some extent, the detection of serum antibodies is useful 
in determing the status and progress of deep fungal infections, including 
human sporotrichosis. But evidence for direct antibody killing of fungi 
is scarce. Ferguson(ll) however, reported that schenckii conidial 
growth was inhibited by incubating conidia in the presence of antiserum. 
Lurie and others(31,33) have demonstrated that S. schenckii conidia and/or 
yeast-phase cells are inhibited within the "asteroid body", an eosinophilic 
immune complex precipitate occurring in histological sections from sporo- 
trichic lesions, and may be converted into "chlamydospores" or (sclerotic 
bodies), i.e., thick-walled, non-proliferating cells, in the presence of 
increasing immunoglobulin titers. Also, it has been reported that C. 
neoformans has been killed in the presence of anti-cryptococcal antibody. 
Also that the C-3 component of complement when activated by ^  albicans, 
via the alternate pathway, has been responsible for direct killing of this 
fungus. Others state that beneficial effects of antibody relative to the 
host against fungi are inconclusive mainly due to lack of serious study.
Aside from any fungicidal effects immunoglobulins may have upon 
fungi, the ability of PECs to phagocytose fungi may be enhanced when 
immunoglobulins coat fungal cells opsonizing them for PECs, augmenting 
phagocytosis.
It is commonly observed in clinical settings that only low numbers 
of fungal elements are normally seen in exudates, tissues, and aspirates 
from humans infected with S. schenckii. Given that human lymphatic phago­
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cytes and interstitial cutaneous histiocytes are approximately equal to 
the guinea pig PECs in phagocytic effectiveness, the result of the 
present work may offer insight into this phenomenon. Since S. schenckii 
antigens are probably ubiquitous in nature, especially on wood products, 
it is likely that humans are normally exposed to at least low numbers of 
these antigens. That exposure can often be confirmed via positive skin 
tests of persons never having had demonstrable sporotrichosis. It stands 
to reason, then, that immunological memory is present to elicit the 
immune response when S. schenckii is encountered in a wound. The PECs, 
of course activated in part by T memory cells, would be highly efficient 
in fungal cell killing. In fact, the observation of low numbers of fungal 
elements seen in fixed cutaneous and other localized atypical sporotrichic 
infections may be indicative of even more effective activation of human 
interstitial histiocytes. The results of Ferguson(11) indicate that this 
concept may reach maxium significance in the alveolar macrophage which are 
generally so efficient in conidial killing that pulmonary disease rarely 
occurs in the normal individual.
In the presence of demonstrable antifungal phagocytic activity as 
portrayed in this work (or equivalently in humans, the interstitial and 
paralymphatic phagocytes) th: chronicity of sporotrichosis in the presence 
of highly efficient phagocytes may be based on the low numbers of normal 
or activated phagocytes present in tissues to remove schenckii com­
pletely, and/or the failure of some phagocytes to be activated, possibly 
because of reduced immune response to schenckii antigens actually 
present in the infection process due to fungal elements being walled off 
in granulomatous lesions and the formation of non-phagocytosing giant cells 
by macrophage fusion.
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In sporotrichosis, as caused by traumatic Implantation of S_̂  schenckii 
Into cutaneous and lymphocutaneous tissues, after about 3 weeks from the 
Initial time of fungal Inplantation, a small, hard movable, nontender nodule 
appears. Histological sections reveal this to be a granulomatous lesion 
containing fungal debris, walled off by phagocytes, elastic fibers, coll­
agenous fibers, and fibrocytes. This walling off of fungal cells may prevent 
B cells from recognizing fungal surface antigens and T cells from receiving 
processed Internal, partially degraded, fungal antigens from giant cells, 
thus Impairing the Immune response. In chronic sporotrichic Infections 
where the fungal elements multiply faster than they can be phagocytosed, 
however, they disseminate through lymphatic vessels, which are normally 
sparse In phagocyte numbers, so fungal proliferation may not be Inhibited. 
Once these fungi have spread to a lymph node, the majority of fungi sus­
pended In the lymph are removed by filtration and phagocytosed by both 
granulocytes and monocytes. Those fungal elements escaping phagocytosis 
are free to proliferate Into the subcutaneous tissue and renew this pro­
cess over and over until a regional lymph node Is encountered. Rarely will
S. schenckii escape complete phagocytosis once contained In one of these 
nodes.
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CHAPTER V 
SUMMARY
Six guinea pig models were treated with ^  schenckii conidia in 
various combinations to ascertain the effects of peritoneal exudate cells 
(PECs) on these conidia, to find whether or not those PEC effects were 
fungicidal or fungistatic to S_̂  schenckii conidia, and to determine the 
effects cortisone compromise had upon PEC activity. Phagocytic responses 
were measured using these 6 animal models which included animals immu­
nized with viable conidia, animals immunized with non-viable conidia, 
untreated controls, animals compromised with hydro-cortisone acetate but 
not immunized, animals both compromised and immunized with viable conidia 
and finally animals both compromised and immunized with non-viable conidia. 
Statistical analyses were used to compare the groups. It appears that 
animals immunized with viable conidia are more efficient in clearing these 
fungi via phagocytosis, that phagocytic rate and fungicidal properties are 
positively correlated, and that cortisone compromise, achieved through 
repeated cortisone injections into these animals, reduces both phagocytic 
ability and fungicidal properties of PECs.
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